课题基金 / 基金详情

Eukaryotic-signaling mediates two-component regulation of GBS virulence

Eukaryotic-signaling mediates two-component regulation of GBS virulence
真核信号介导 GBS 毒力的双组分调节
批准号:
8663520
负责人:
Lakshmi Rajagopal
金额:
$48.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2014-12-31

项目摘要

项目成果

Lakshmi Rajagopal的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):人类新生儿的发病率和死亡率是重大的公共卫生问题。B群链球菌(GBS)是人类新生儿早产、死产和早发性败血症的重要原因。虽然GBS通常以共生体形式存在于健康妇女的下生殖道(LGT)中,但促进GBS从LGT向胎儿传播的事件尚不清楚。宫内GBS感染上升的重要毒力因素尚未确定。利用人胎盘和豚鼠宫内感染模型,本研究的目的是确定激活毒力基因表达的分子机制,以促进GBS感染和胎儿损伤。
英文摘要
DESCRIPTION (provided by applicant): Morbidity and mortality of human newborns are significant public health concerns. Group B Streptococci (GBS) are a significant cause of preterm births, stillbirths and early onset sepsis in human newborns. Although GBS normally reside as commensals in the lower genital tract (LGT) of healthy women, the events that promote transmission of GBS from the LGT to the fetus are unknown. Virulence factors important for ascending in utero GBS infections have not been established. Using human placenta and a guinea pig model of intrauterine infection, the objective of this proposal is to define molecular mechanisms that activate virulence gene expression for ascending GBS infection and fetal injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neutralizing the GBS hemolytic lipid toxin
  • 批准号:
    10392131
  • 项目类别:
  • 资助金额:
    $80.59万
  • 财政年份:
    2022
  • 负责人:
    Lakshmi Rajagopal
  • 依托单位:
Neutralizing the GBS hemolytic lipid toxin
  • 批准号:
    10647649
  • 项目类别:
  • 资助金额:
    $82.33万
  • 财政年份:
    2022
  • 负责人:
    Lakshmi Rajagopal
  • 依托单位:
Role of human cervical mucus plugs in ascending GBS infection
  • 批准号:
    9303886
  • 项目类别:
  • 资助金额:
    $23.37万
  • 财政年份:
    2016
  • 负责人:
    Lakshmi Rajagopal
  • 依托单位:
Role of human cervical mucus plugs in ascending GBS infection
  • 批准号:
    9165076
  • 项目类别:
  • 资助金额:
    $30.45万
  • 财政年份:
    2016
  • 负责人:
    Lakshmi Rajagopal
  • 依托单位:
海外基金